Skip to main content

Daxor Corp

DXR
Exchange
Nasdaq
SEC CIK
0000027367

No open-market purchases or sales by Daxor Corp insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.33M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Daxor Corp changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of DXR: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders9115+7
Shares96.7K49.0K420.1K+372.4K (+781.1%)
Value$1.43M$723.2K$4.07M+$3.36M (+478.4%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Daxor Corp at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to DXR in Q1 2026
InstitutionSharesValue% of portfolio
Thompson Siegel & Walmsley LLC232,120$2.25M0.04%
Vanguard Capital Management LLC48,280$469.3K0.00%
Aristides Capital LLC41,692$403.2K0.13%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management25,192$244.9K0.00%
Susquehanna International Group, LLP13,720$133.4K0.00%
Crescent Grove Advisors, LLC10,723$103.7K0.01%
Vanguard Fiduciary Trust Co1,037$10.1K0.00%
Tower Research Capital LLC (TRC)109$1.05K0.00%

Sold out (1)

Institutions that held Daxor Corp at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of DXR in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
UBS Group AG90$1.33K

Not filed for Q1 2026 yet (1)

Institutions that held Daxor Corp at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DXR in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc49,028$723.2K